BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33630379)

  • 1. Estimating the potential impact of interventions to reduce over-calling and under-calling of melanoma.
    Gibson M; Scolyer RA; Soyer HP; Ferguson P; McGeechan K; Irwig L; Bell KJL
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1519-1527. PubMed ID: 33630379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
    Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
    JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.
    Massi D; Szumera-Ciećkiewicz A; Alos L; Simi S; Ugolini F; Palmieri G; Stanganelli I; Cook MG; Mandalà M
    Eur J Cancer; 2023 Aug; 189():112921. PubMed ID: 37280145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party.
    Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ
    J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs.
    Tosteson ANA; Tapp S; Titus LJ; Nelson HD; Longton GM; Bronson M; Pepe M; Carney PA; Onega T; Piepkorn MW; Knezevich SR; Barnhill R; Weinstock MA; Elder DE; Elmore JG
    JAMA Dermatol; 2021 Sep; 157(9):1102-1106. PubMed ID: 34076664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions.
    van Dijk MC; Aben KK; van Hees F; Klaasen A; Blokx WA; Kiemeney LA; Ruiter DJ
    Histopathology; 2008 Jan; 52(2):139-46. PubMed ID: 18184263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
    Shoo BA; Sagebiel RW; Kashani-Sabet M
    J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic.
    McGinnis KS; Lessin SR; Elder DE; Guerry D; Schuchter L; Ming M; Elenitsas R
    Arch Dermatol; 2002 May; 138(5):617-21. PubMed ID: 12020222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and referral accuracy of family doctors in melanoma screening: effect of a short formal training.
    Carli P; De Giorgi V; Crocetti E; Caldini L; Ressel C; Giannotti B
    Eur J Cancer Prev; 2005 Feb; 14(1):51-5. PubMed ID: 15677895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists.
    Farmer ER; Gonin R; Hanna MP
    Hum Pathol; 1996 Jun; 27(6):528-31. PubMed ID: 8666360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological diagnosis of cutaneous melanocytic lesions: blinded and nonblinded second opinions offer similar improvement in diagnostic accuracy.
    Kerr KF; Longton GM; Reisch LM; Radick AC; Eguchi MM; Shucard HL; Pepe MS; Piepkorn MW; Elder DE; Barnhill RL; Elmore JG
    Clin Exp Dermatol; 2022 Sep; 47(9):1658-1665. PubMed ID: 35426450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What criteria reliably distinguish melanoma from benign melanocytic lesions?
    Okun MR; Edelstein LM; Kasznica J; Kirkham N; Slater DN
    Histopathology; 2000 Nov; 37(5):464-72. PubMed ID: 11119130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.
    Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R
    JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.
    Elder DE; Piepkorn MW; Barnhill RL; Longton GM; Nelson HD; Knezevich SR; Pepe MS; Carney PA; Titus LJ; Onega T; Tosteson ANA; Weinstock MA; Elmore JG
    J Am Acad Dermatol; 2018 Jul; 79(1):52-59.e5. PubMed ID: 29524584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
    Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
    JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic significance of the blue hue in dermoscopy of melanocytic lesions: a dermoscopic-pathologic study.
    Massi D; De Giorgi V; Carli P; Santucci M
    Am J Dermatopathol; 2001 Oct; 23(5):463-9. PubMed ID: 11801781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions.
    Onega T; Barnhill RL; Piepkorn MW; Longton GM; Elder DE; Weinstock MA; Knezevich SR; Reisch LM; Carney PA; Nelson HD; Radick AC; Elmore JG
    JAMA Dermatol; 2018 Oct; 154(10):1159-1166. PubMed ID: 30140929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
    Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
    Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting.
    Lodha S; Saggar S; Celebi JT; Silvers DN
    J Cutan Pathol; 2008 Apr; 35(4):349-52. PubMed ID: 18333894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation.
    Pusiol T; Morichetti D; Piscioli F; Zorzi MG
    Pathologica; 2012 Apr; 104(2):70-7. PubMed ID: 22953503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.